- Design a marketing strategy
- Launch a new product
- Evaluate a brand's performance
- Optimize promotional spending
- Educate prescribers
- Educate nursing & allied health professionals
- Reinforce a product coming off patent
- Develop a continuing education program
- Train & manage a sales force
- Evaluate the impact of managed care on a brand
- Assess published & ongoing clinical trials
- Evaluate competitors' pipelines
- Track patents & validate patent claims
- Stay on top of news & adverse events
- Track & analyze competitors' marketing claims
- Develop a document management system
- Obtain medical artwork or images
- Request more information
- Strategic communications planning
- Market & competitive intelligence
- Access aids & tools
- Key opinion leader development
- Detail & presentation aids
- Brand development
- Continuing education programs
- Healthcare analytics
- Publications planning
- Medical artwork & images
- Meeting reporting & analysis
- Sales management tools
- Sales training aids
- Event planning
- eHealthcare programs
- Journal subscriptions
- Rapid Publishing Service
- Request more information
Throughout the pharmaceutical lifecycle you face critical decisions. Which targets should I pursue? How do I best position my product? What's the best way to educate my audience? Are there competitive threats emerging? Wolters Kluwer Health has amassed the industry's best resources to help you answer these questions.
Learn more
Medicare Part D Market Dynamics Whitepaper:
This Wolters Kluwer Health whitepaper examines the impact of Medicare Part D in 2006 and first quarter 2007, specifically its effect on patient behavior and the overall implications for the pharmaceutical sector.
View Whitepaper (PDF)
The newly expanded Adis Clinical Trials Insight
Clinical Trials Insight includes not only difficult-to-monitor ongoing studies, but all studies presented at the top 100 meetings and published in leading medical journals.
Updated daily, Clinical Trials Insight continues to provide you with an unrivalled assessment of the clinical trials landscape, now with even greater coverage than before.
Learn more
This Wolters Kluwer Health whitepaper examines the impact of Medicare Part D in 2006 and first quarter 2007, specifically its effect on patient behavior and the overall implications for the pharmaceutical sector.
View Whitepaper (PDF)
The newly expanded Adis Clinical Trials Insight
Clinical Trials Insight includes not only difficult-to-monitor ongoing studies, but all studies presented at the top 100 meetings and published in leading medical journals.
Updated daily, Clinical Trials Insight continues to provide you with an unrivalled assessment of the clinical trials landscape, now with even greater coverage than before.
Learn more